Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS)

CUSIP: 64134X201

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,508,976
Total 13F shares
809,096
Share change
-35,414
Total reported value
$2,492,424
Price per share
$3.08
Number of holders
18
Value change
+$6,434
Number of buys
9
Number of sells
4

Security key

64134X201

Report period

Q3 2025

Institutions

18

Top holders

10

Top shareholders of NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Brian P. Hannasch
13D/G
12%
1,144,374
$3,387,347 +$1,274,446 01 Jul 2025
AIGH Capital Management LLC
13F
Company
3.5%
400,000
$968,000 30 Jun 2025
13F
APIS CAPITAL ADVISORS, LLC
13F
Company
1.1%
124,024
$300,138 30 Jun 2025
13F
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
1%
116,726
$282,477 30 Jun 2025
13F
Manatuck Hill Partners, LLC
13F
Company
0.44%
50,416
$122,007 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
0.24%
27,981
$67,714 30 Jun 2025
13F
STIFEL FINANCIAL CORP
13F
Company
0.22%
25,710
$62,218 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.22%
25,524
$61,768 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.21%
24,278
$58,752 30 Jun 2025
13F
Wealthcare Advisory Partners LLC
13F
Company
0.13%
15,188
$36,755 30 Jun 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.13%
15,101
$37,000 30 Jun 2025
13F
LPL Financial LLC
13F
Company
0.09%
10,000
$24,200 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.05%
5,802
$14,041 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
2,145
$5,191 30 Jun 2025
13F
Ulland Investment Advisors, LLC
13F
Company
0.01%
1,000
$2,000 30 Jun 2025
13F
UBS Group AG
13F
Company
0%
575
$1,392 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
31
$75 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
9
$22 30 Jun 2025
13F
Christopher Robin Brown
3/4/5
DIRECTOR OF INNOVATION, Director
class O/S missing
792,837
$2,069,305 08 Aug 2023
Gary Merril Peterson
3/4/5
DIR.OF DESIGN & ENGINEERING
class O/S missing
518,120
$1,352,293 08 Aug 2023

Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q3 2025

As of 30 Sep 2025, Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 809,096 shares. The largest 10 holders included AIGH Capital Management LLC, PARSONS CAPITAL MANAGEMENT INC/RI, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, MONEY CONCEPTS CAPITAL CORP, STIFEL FINANCIAL CORP, XTX Topco Ltd, Wealthcare Advisory Partners LLC, and ROYAL BANK OF CANADA. This page lists 18 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
17
Q3 2025 holders
18
Holder diff
1
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .